About
Tear Encouragement Device
Areas of Focus
Categories
Uncategorized Medical DeviceSeattle/Pacific Northwest
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
365
By Phase
PHASE1: 1PHASE4: 2NA: 1
By Status
UNKNOWN: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06235450Lead Sponsor
A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation
PHASE1Recruiting
200 participants
Started: Jan 19, 2024 · Completed: Dec 31, 2025
NCT05304637Lead Sponsor
Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients
PHASE4Unknown
30 participants
Started: Mar 1, 2022 · Completed: Jul 1, 2022
NCT05304650Lead Sponsor
A Usability Study of External Neuromodulation With iTEAR100 Generation 2
PHASE4Unknown
100 participants
Started: Mar 1, 2022 · Completed: Jun 15, 2022
NCT04763018Lead Sponsor
Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users
NAUnknown
35 participants
Started: Feb 17, 2021 · Completed: Jun 1, 2021
Locations (1)
Headquarters
Issaquah, WA, United States
Map
Loading map...